Donald Trump Orders New Pharmaceutical and Metals Tariffs

U.S. President Donald Trump has ordered significant changes to the nation's tariff policies, introducing up to 100% tariffs on certain branded pharmaceutical imports and overhauling duties on steel, aluminum, and copper. These actions aim to rebuild tariffs lost after the United States===Supreme Court of the United States struck down previous broad global tariffs and to incentivize foreign manufacturers to cut prescription drug prices and move production to the United States. Pharmaceutical companies must agree to both conditions to avoid tariffs entirely, with a 20% tariff for partial relocation and 100% for non-compliance. Tariffs on branded drugs from the European Union, Japan, South Korea, and Switzerland will be capped at 15%, while the United States and United Kingdom finalized a deal for zero tariffs on British-made pharmaceuticals for three years. Metals tariffs were adjusted, halving duties to 25% on many derivative products and eliminating them for goods with minimal metal content, while maintaining a 50% duty on core commodity imports, now applied to the U.S. sales price. These changes are intended to simplify the tariff regime and support domestic industries, though business groups like the United States Chamber of Commerce have expressed concerns about rising costs, while the Steel Manufacturers Association welcomed the adjustments.